LAG3 and neoplasm: Our study suggests that anti-PD-1 immunotherapy-resistant Hodgkin lymphoma could correlate in tumor microenvironment with an immune depletion of CD8+ T lymphocytes and overexpression of LAG-3 on CD4+ helper T lymphocytes.